位置:首页 > 蛋白库 > ARE_SACSO
ARE_SACSO
ID   ARE_SACSO               Reviewed;         306 AA.
AC   B5BLW5;
DT   17-FEB-2016, integrated into UniProtKB/Swiss-Prot.
DT   23-SEP-2008, sequence version 1.
DT   03-AUG-2022, entry version 34.
DE   RecName: Full=Arylesterase {ECO:0000303|PubMed:18931117};
DE            Short=A-esterase {ECO:0000303|PubMed:18931117};
DE            EC=3.1.1.2 {ECO:0000269|PubMed:18931117};
DE   AltName: Full=Paraoxonase {ECO:0000303|PubMed:18931117};
DE            EC=3.1.8.1 {ECO:0000269|PubMed:18931117};
GN   Name=are {ECO:0000303|PubMed:18931117};
OS   Saccharolobus solfataricus (Sulfolobus solfataricus).
OC   Archaea; Crenarchaeota; Thermoprotei; Sulfolobales; Sulfolobaceae;
OC   Saccharolobus.
OX   NCBI_TaxID=2287 {ECO:0000312|EMBL:CAR57941.1};
RN   [1] {ECO:0000312|EMBL:CAR57941.1}
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], PROTEIN SEQUENCE OF 14-20, FUNCTION,
RP   CATALYTIC ACTIVITY, ACTIVITY REGULATION, BIOPHYSICOCHEMICAL PROPERTIES,
RP   SUBSTRATE SPECIFICITY, SUBUNIT, MASS SPECTROMETRY, AND MUTAGENESIS OF
RP   CYS-105; CYS-107; CYS-129; SER-156; ASP-251 AND HIS-281.
RC   STRAIN=ATCC 35091 / DSM 1616 / JCM 8930 / NBRC 15331 / P1
RC   {ECO:0000303|PubMed:18931117};
RX   PubMed=18931117; DOI=10.1128/jb.00803-08;
RA   Park Y.J., Yoon S.J., Lee H.B.;
RT   "A novel thermostable arylesterase from the archaeon Sulfolobus
RT   solfataricus P1: purification, characterization, and expression.";
RL   J. Bacteriol. 190:8086-8095(2008).
CC   -!- FUNCTION: Has a broad substrate specificity. Hydrolyzes various p-
CC       nitrophenyl phosphates, aromatic esters and p-nitrophenyl fatty acids
CC       in vitro. Most active against paraoxon, phenyl acetate and p-
CC       nitrophenyl caproate (C6), respectively. Has also tributyrinase
CC       activity, but shows no hydrolytic activity toward other
CC       triacylglycerols including tricaprylin, trimyristin, tripalmitin or
CC       triolein in vitro. {ECO:0000269|PubMed:18931117}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a phenyl acetate + H2O = a phenol + acetate + H(+);
CC         Xref=Rhea:RHEA:17309, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:30089, ChEBI:CHEBI:33853, ChEBI:CHEBI:140310; EC=3.1.1.2;
CC         Evidence={ECO:0000269|PubMed:18931117};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=An aryl dialkyl phosphate + H2O = dialkyl phosphate + an aryl
CC         alcohol.; EC=3.1.8.1; Evidence={ECO:0000269|PubMed:18931117};
CC   -!- ACTIVITY REGULATION: Completely inhibited by chemical modifiers that
CC       are specific to Cys (HgCl(2) and p-chloromercuribenzoic acid), His
CC       (diethyl pyrocarbonate) and Ser (diisopropyl fluorophosphate and
CC       phenylmethanesulfonyl fluoride). No significant effect with chemical
CC       modifiers specific to Lys (pyridoxal 5'-phosphate) and Arg
CC       (phenylglyoxal). Not inhibited by inhibitors of A-esterases (paraoxon)
CC       or C-esterases (physostigmine/eserine). Activity is also not effected
CC       by incubation with 5 mM divalent cations for 30 minutes at 30 degrees
CC       Celsius or with 10 mM EDTA for 60 minutes at 75 degrees Celsius.
CC       {ECO:0000269|PubMed:18931117}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=17 uM for phenyl acetate (PA) {ECO:0000269|PubMed:18931117};
CC         KM=29 uM for alpha-naphthyl acetate (alpha-NA)
CC         {ECO:0000269|PubMed:18931117};
CC         KM=224 uM for p-nitrophenyl butyrate (C4)
CC         {ECO:0000269|PubMed:18931117};
CC         KM=31 uM for p-nitrophenyl caproate (C6)
CC         {ECO:0000269|PubMed:18931117};
CC         KM=28 uM for p-nitrophenyl caprylate (C8)
CC         {ECO:0000269|PubMed:18931117};
CC         KM=81 uM for p-nitrophenyl caprate (C10)
CC         {ECO:0000269|PubMed:18931117};
CC         KM=122 uM for p-nitrophenyl laurate (C12)
CC         {ECO:0000269|PubMed:18931117};
CC         KM=276 uM for p-nitrophenyl palmitate (C16)
CC         {ECO:0000269|PubMed:18931117};
CC         KM=234 uM for p-nitrophenyl phosphate {ECO:0000269|PubMed:18931117};
CC         KM=5 uM for paraoxon {ECO:0000269|PubMed:18931117};
CC         KM=246 uM for methyl paraoxon {ECO:0000269|PubMed:18931117};
CC         Note=kcat is 521 sec(-1) with PA as substrate. kcat is 450 sec(-1)
CC         with alpha-NA as substrate. kcat is 285 sec(-1) with p-nitrophenyl
CC         butyrate (C4) as substrate. kcat is 467 sec(-1) with p-nitrophenyl
CC         caproate (C6) as substrate. kcat is 410 sec(-1) with p-nitrophenyl
CC         caprylate (C8) as substrate. kcat is 341 sec(-1) with p-nitrophenyl
CC         caprate (C10) as substrate. kcat is 264 sec(-1) with p-nitrophenyl
CC         laurate (C12) as substrate. kcat is 265 sec(-1) with p-nitrophenyl
CC         palmitate (C16) as substrate. kcat is 269 sec(-1) with p-nitrophenyl
CC         phosphate as substrate. kcat is 597 sec(-1) with paraoxon as
CC         substrate. kcat is 342 sec(-1) with methyl paraoxon as substrate.
CC         {ECO:0000269|PubMed:18931117};
CC       pH dependence:
CC         Optimum pH is 7.0. {ECO:0000269|PubMed:18931117};
CC       Temperature dependence:
CC         Optimum temperature is 94 degrees Celsius. Very thermostable, but
CC         rapidly inactivated above 94 degrees Celsius. Most of the activity is
CC         retained for 5 days at 50 degrees Celsius, and approximately 70% of
CC         the activity is retained after 5 days at 70 degrees Celsius. 52% of
CC         the activity is still retained after 50 hours at 90 degrees Celsius,
CC         but completely inactivated after 5 days at 90 degrees Celsius.
CC         {ECO:0000269|PubMed:18931117};
CC   -!- SUBUNIT: Monomer. {ECO:0000269|PubMed:18931117}.
CC   -!- MASS SPECTROMETRY: Mass=35174.88; Method=MALDI;
CC       Evidence={ECO:0000269|PubMed:18931117};
CC   -!- SIMILARITY: Belongs to the 'GDXG' lipolytic enzyme family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; FM205057; CAR57941.1; -; Genomic_DNA.
DR   PDB; 5L2P; X-ray; 2.56 A; A/B/C/D=1-306.
DR   PDBsum; 5L2P; -.
DR   AlphaFoldDB; B5BLW5; -.
DR   SMR; B5BLW5; -.
DR   ESTHER; sulac-q4j9s2; Hormone-sensitive_lipase_like.
DR   BioCyc; MetaCyc:MON-20863; -.
DR   BRENDA; 3.1.1.2; 6163.
DR   BRENDA; 3.1.8.1; 6163.
DR   GO; GO:0004063; F:aryldialkylphosphatase activity; IDA:UniProtKB.
DR   GO; GO:0004064; F:arylesterase activity; IDA:UniProtKB.
DR   GO; GO:0019439; P:aromatic compound catabolic process; IDA:UniProtKB.
DR   Gene3D; 3.40.50.1820; -; 1.
DR   InterPro; IPR029058; AB_hydrolase.
DR   InterPro; IPR013094; AB_hydrolase_3.
DR   Pfam; PF07859; Abhydrolase_3; 1.
DR   SUPFAM; SSF53474; SSF53474; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Direct protein sequencing; Hydrolase; Serine esterase.
FT   CHAIN           1..306
FT                   /note="Arylesterase"
FT                   /id="PRO_0000435565"
FT   MOTIF           82..84
FT                   /note="Involved in the stabilization of the negatively
FT                   charged intermediate by the formation of the oxyanion hole"
FT                   /evidence="ECO:0000250|UniProtKB:Q5NUF3"
FT   ACT_SITE        156
FT                   /evidence="ECO:0000305|PubMed:18931117"
FT   ACT_SITE        251
FT                   /evidence="ECO:0000305|PubMed:18931117"
FT   ACT_SITE        281
FT                   /evidence="ECO:0000305|PubMed:18931117"
FT   MUTAGEN         105
FT                   /note="C->S: 3-fold loss of activity compared to wild-
FT                   type."
FT                   /evidence="ECO:0000269|PubMed:18931117"
FT   MUTAGEN         107
FT                   /note="C->S: 4-fold loss of activity compared to wild-
FT                   type."
FT                   /evidence="ECO:0000269|PubMed:18931117"
FT   MUTAGEN         129
FT                   /note="C->S: 28-fold loss of activity compared to wild-
FT                   type."
FT                   /evidence="ECO:0000269|PubMed:18931117"
FT   MUTAGEN         156
FT                   /note="S->A: Nearly loss of activity."
FT                   /evidence="ECO:0000269|PubMed:18931117"
FT   MUTAGEN         251
FT                   /note="D->N: Nearly loss of activity."
FT                   /evidence="ECO:0000269|PubMed:18931117"
FT   MUTAGEN         281
FT                   /note="H->N: 5-fold loss of activity compared to wild-
FT                   type."
FT                   /evidence="ECO:0000269|PubMed:18931117"
FT   HELIX           5..17
FT                   /evidence="ECO:0007829|PDB:5L2P"
FT   TURN            22..24
FT                   /evidence="ECO:0007829|PDB:5L2P"
FT   HELIX           27..39
FT                   /evidence="ECO:0007829|PDB:5L2P"
FT   STRAND          48..56
FT                   /evidence="ECO:0007829|PDB:5L2P"
FT   STRAND          61..68
FT                   /evidence="ECO:0007829|PDB:5L2P"
FT   STRAND          77..81
FT                   /evidence="ECO:0007829|PDB:5L2P"
FT   TURN            85..87
FT                   /evidence="ECO:0007829|PDB:5L2P"
FT   TURN            91..94
FT                   /evidence="ECO:0007829|PDB:5L2P"
FT   HELIX           95..105
FT                   /evidence="ECO:0007829|PDB:5L2P"
FT   STRAND          107..112
FT                   /evidence="ECO:0007829|PDB:5L2P"
FT   TURN            117..119
FT                   /evidence="ECO:0007829|PDB:5L2P"
FT   HELIX           124..138
FT                   /evidence="ECO:0007829|PDB:5L2P"
FT   HELIX           140..143
FT                   /evidence="ECO:0007829|PDB:5L2P"
FT   STRAND          150..155
FT                   /evidence="ECO:0007829|PDB:5L2P"
FT   HELIX           157..171
FT                   /evidence="ECO:0007829|PDB:5L2P"
FT   STRAND          177..183
FT                   /evidence="ECO:0007829|PDB:5L2P"
FT   HELIX           193..197
FT                   /evidence="ECO:0007829|PDB:5L2P"
FT   STRAND          198..203
FT                   /evidence="ECO:0007829|PDB:5L2P"
FT   STRAND          208..210
FT                   /evidence="ECO:0007829|PDB:5L2P"
FT   HELIX           212..217
FT                   /evidence="ECO:0007829|PDB:5L2P"
FT   HELIX           221..225
FT                   /evidence="ECO:0007829|PDB:5L2P"
FT   TURN            227..229
FT                   /evidence="ECO:0007829|PDB:5L2P"
FT   HELIX           231..233
FT                   /evidence="ECO:0007829|PDB:5L2P"
FT   STRAND          242..250
FT                   /evidence="ECO:0007829|PDB:5L2P"
FT   HELIX           254..266
FT                   /evidence="ECO:0007829|PDB:5L2P"
FT   STRAND          271..280
FT                   /evidence="ECO:0007829|PDB:5L2P"
FT   HELIX           281..283
FT                   /evidence="ECO:0007829|PDB:5L2P"
FT   HELIX           287..305
FT                   /evidence="ECO:0007829|PDB:5L2P"
SQ   SEQUENCE   306 AA;  34552 MW;  69DB277CFC26F24B CRC64;
     MPLDPEVRNF LQVYYKANII DFTKYQFQEI RQKVNELLAK AVPKDPVGET RDMKIKLEDY
     ELPIRIYSPI KRTNNGLVMH FHGGAWILGS IETEDAISRI LSNSCECTVI SVDYRLAPEY
     KFPTAVYDCF NAIVWARDNA GELGIDKDKI ATFGISAGGN LVAATSLLAR DNKLKLTAQV
     PVVPFVYLDL ASKSMNRYRK GYFLDINLPV DYGVKMYIRD EKDLYNPLFS PLIAEDLSNL
     PQAIVVTAEY DPLRDQGEAY AYRLMESGVP TLSFRVNGNV HAFLGSPRTS RQVTVMIGAL
     LKDIFK
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024